Neutrophils are the most abundant immune cells in the body and the first to respond to infection or tissue damage. Yet despite their importance, until ...

A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment - an advance ...

We're delighted to share our Knowledge team's insights on the most important legal changes affecting the Health & Life Sciences sector around ...

EHE Health, a national preventive healthcare provider, is introducing a first-of-its-kind VO2 max testing innovation to the United States to help patients better understand and manage their ...

Profound Medical Corp. ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection technology, today announced the presentation of multiple lymphoma studies featuring Foresight CLARITY™ ...

Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an ...

Europe must reform the ways in which science is evaluated. To boost innovation, it must improve research culture.

HealthDay News — Routine first-trimester ultrasounds lead to earlier detection of fetal anomalies, according to a study published online Nov. 25 in PLOS Medicine.

Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer’s disease by up to 8.3 years in low-amyloid group who started ...

Robertson has seen a “big movement” of influencers on social media encouraging people to come off their medicines for conditions such as ulcerative colitis—suggesting, for instance, that it can be ...